Correlation Between 23Andme Holding and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Inhibikase Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Inhibikase Therapeutics.
Diversification Opportunities for 23Andme Holding and Inhibikase Therapeutics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between 23Andme and Inhibikase is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Inhibikase Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to generate 1.13 times more return on investment than Inhibikase Therapeutics. However, 23Andme Holding is 1.13 times more volatile than Inhibikase Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about -0.18 per unit of risk. If you would invest 306.00 in 23Andme Holding Co on October 20, 2024 and sell it today you would earn a total of 55.00 from holding 23Andme Holding Co or generate 17.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Inhibikase Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Inhibikase Therapeutics |
23Andme Holding and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Inhibikase Therapeutics
The main advantage of trading using opposite 23Andme Holding and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |